Exacerbation of Psychogenic Movement Disorder by Interferon{alpha} Treatment of Hepatitis C

Psychosomatics. 2007 Jan-Feb;48(1):86-7. doi: 10.1176/appi.psy.48.1.86.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Citalopram / therapeutic use
  • Combined Modality Therapy
  • Depressive Disorder / diagnosis
  • Depressive Disorder / psychology
  • Depressive Disorder / therapy
  • Disease Progression
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / psychology
  • Humans
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Male
  • Middle Aged
  • Movement Disorders / diagnosis*
  • Movement Disorders / psychology
  • Movement Disorders / therapy
  • Psychophysiologic Disorders / diagnosis*
  • Psychophysiologic Disorders / psychology
  • Psychophysiologic Disorders / therapy
  • Psychotherapy

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Citalopram